After the transfusion of compatible maternal P1 A1 -negative platelets, there was a sustained improvement in the platelet count and cessation of hemorrhage.

Patients with confirmed immunological refractoriness because of the presence of HLA antibodies require transfusions of HLA-matched or HLA compatible platelets.

Splenectomy was performed without complication in all 3 and was followed by improved response to platelet transfusion and longer post-transfusion survival of platelets.

About Secure Transfusion Solutions Secure Transfusion Solutions (STS) is a life sciences company pioneering innovative methods to overcome the nation’s growing blood and platelet shortage.